person

Bertil E.

Country
Sweden
Department
Medicinmottagningen

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 6 partner sites.

Specializations

Cardiovascular Medicine

The investigator concentrates on acute myocardial infarction, heart failure, atrial fibrillation, and left ventricular thrombus, with an emphasis on stroke prevention strategies.

  • Acute myocardial infarction
  • Heart failure with reduced ejection fraction
  • Atrial fibrillation
  • Left ventricular thrombus
  • Stroke prophylaxis

Research integrates novel anticoagulants and rapid‑acting agents to improve acute and chronic cardiac outcomes.

Renal & Anticoagulation

Work in this area addresses chronic kidney disease stage 5 patients, evaluating anticoagulant safety and management of high‑risk hyperkalemia.

  • CKD stage 5 anticoagulation
  • Apixaban safety in dialysis
  • Hyperkalemia management

Studies combine renal function assessment with thrombotic risk reduction.

Infectious Diseases & Antibiotic Strategies

Focuses on combating multidrug‑resistant urinary tract infections, optimizing therapy for tuberculosis, and preventing prosthetic joint infection.

  • ESBL‑producing Enterobacterales UTIs
  • Shortened TB regimens
  • Antibiotic‑impregnated bone grafts

Efforts prioritize antimicrobial stewardship and device‑related infection control.

Oncology & Molecular Targeted Therapy

Investigates colorectal cancer with PIK3CA/PIK3R1/PTEN alterations and evaluates adjuvant strategies such as aspirin.

  • PIK3CA‑mutated colorectal cancer
  • Aspirin adjuvant therapy
  • Molecularly guided treatment

Research aligns with precision oncology approaches.

Endocrinology & Autoimmune Disorders

Encompasses studies on type 1 diabetes, autoimmune premature ovarian insufficiency, and immune‑modulating treatment for schizophrenia spectrum disorder.

  • Type 1 diabetes beta‑cell preservation
  • Autoimmune POI rituximab therapy
  • Rituximab in schizophrenia

Efforts explore immune‑targeted interventions across endocrine and psychiatric conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.